Interview with IG UK
N4 Pharma's CEO, Nigel Theobald, has been interviewed by IG UK on the company's growth so far and some of the research we are currently working on. Watch the interview in full below.
Nuvec®’s potential in the fight for a vaccine against COVID-19
Our CEO, Nigel Theobald, has written an article for Drug Discovery Today about the emerging vaccine delivery systems for COVID-19. He talks about how functionalised silica nanoparticles, like Nuvec®, offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines, and may be useful in the race to [...]
Directors Talk interview: N4 Pharma is “entering a defining period”
After the release of our interim results this week, we're pleased to share another interview between N4 Pharma's CEO, Nigel Theobald, and Directors Talk. Nigel discusses the progress made with Nuvec® research projects in the last half and explains our strategy as we move forward with our work – [...]
Proof of concept project update: interview with Directors Talk
N4 Pharma's CEO, Nigel Theobald, has spoken to Directors Talk to give an update on our Covid-19 proof of concept project, and our ongoing work to show Nuvec®'s potential use with multiple vaccines. Watch the interview in full below or read the article. https://vimeo.com/457689117
New article with ONdrugDelivery: challenges of oligonucleotide delivery
Our latest article in the May issue of ONdrugDelivery features our CEO, Nigel Theobald, discussing the challenges of oligonucleotide delivery and explores approaches to overcome them. Head to page 68-72 to read more.
Nigel Theobald on revolutionising silica nanoparticle drug delivery
The March issue of Pharma's Almanac features our CEO, Nigel Theobald, discussing the advantages of silica and our work with Nuvec® to improve drug delivery systems for nucleic acid-based cancer immunotherapies and viral vaccines. Click here to read more.
N4 Pharma and Proactive discuss the latest update on Nuvec®
Our CEO, Nigel Theobald, recently provided an update on our Nuvec® program following the release of our interim results. You can watch the full interview with Proactive London's Andrew Scott below or visit the website: https://bit.ly/2lU6O78. https://www.youtube.com/watch?time_continue=776&v=TJVlEOs8TEE
Catching up with The Medicine Maker
Our CEO, Nigel Theobald, recently caught up with The Medicine Maker to discuss the story behind N4 Pharma and give his advice to entrepreneurs in the pharmaceutical industry. Click here to create your logins and read the full article.
Nigel Theobald discusses the benefits of nanotechnology
N4 Pharma has been featured in the latest issue of BioPharm International.
Catching up in Cambridge
We recently joined a full house of attendees at CrownBio’s annual conference.